GLP-1 Receptor Agonist Market Size and Trends Forecast: 2026 - 2033 GLP-1 receptor agonist market is estimated to be valued at USD 31.71 Bn in 2026 and is expected to reach USD 72.33 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033
Side Effects Common (mild, usually temporary): Nausea, vomiting, diarrhea, abdominal discomfort, decreased appetite, constipation, or headache
These mechanisms represent potential therapeutic targets for CF treatment through modulation of post-translational modifications in the CFTR maturation pathway (Zaman et al., 2019)
All patients were either obese or overweight and had a history of heart disease
The age group with the most respondents that had never attempted weight loss was the over 55s, with 36% saying they had never done so before
Polonikov, 2020